{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:59:45Z","timestamp":1787169585717,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Chronic Myeloid Leukemia (CML) is one of the myeloproliferative disorders characterized by Philadelphia chromosome presence. Contrary to Western countries, most CML patients in Indonesia present symptoms with splenomegaly as the most common finding. It is rare to find asymptomatic CML patients. We present a case of asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL (+) without splenomegaly who achieved a hematologic and molecular response to imatinib.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_1401_21","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T05:49:43Z","timestamp":1647409783000},"page":"373-375","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL. (+) without splenomegaly"],"prefix":"10.4103","volume":"25","author":[{"given":"W","family":"Rajabto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YK","family":"Angkasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20240907","doi-asserted-by":"crossref","first-page":"iv41","DOI":"10.1093\/annonc\/mdx219","article-title":"Chronic myeloid leukemia: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up","volume":"28","author":"Hochhaus","year":"2017","journal-title":"Ann Oncol"},{"key":"R2-24-20240907","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4082\/kjfm.2015.36.5.197","article-title":"An overview and update of chronic myeloid leukemia for primary care physicians","volume":"36","author":"Granatowicz","year":"2015","journal-title":"Korean J Fam Med"},{"key":"R3-24-20240907","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7454\/jpdi.v5i1.167","article-title":"Association of clinical features and hematological laboratories between Ph (+)\/BCL-ABL (+) chronic myeloid leukemia and other type of Ph\/BCL-ABL chronic myeloid leukemia","volume":"5","author":"Rajabto","year":"2018","journal-title":"Jurnal Penyakit Dalam Indonesia"},{"key":"R4-24-20240907","first-page":"54","article-title":"Current Treatment Approaches in CML","volume":"3","author":"Castagnetti","year":"2019","journal-title":"Hemasphere Educational Updates in Hematology Book"},{"key":"R5-24-20240907","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ajh.25792","article-title":"Chronic myeloid leukemia: 2020 update on diagnosis, therapy, and monitoring","volume":"95","author":"Jabbour","year":"2020","journal-title":"Am J Hematol"},{"key":"R6-24-20240907","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.16971","article-title":"A british society for haematology guideline on the diagnosis and management of chronic leukemoid leukemia","volume":"191","author":"Smith","year":"2020","journal-title":"Br J Heamatol"},{"key":"R7-24-20240907","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1080\/10428194.2017.1379074","article-title":"First-line therapy for chronic phase CML: Selecting the optimal BCR-ABL1-targeted TKI","volume":"59","author":"Saglio","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"R8-24-20240907","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41375-020-0776-2","article-title":"European leukemia NET 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus","year":"2020","journal-title":"Leukemia"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1401_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:09:25Z","timestamp":1787166565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1401_21"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_1401_21","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}